AddLife (ALIF B.ST) Stock Price

AddLife Price

OMX·CLOSED
159.60SEK+2.10 (+1.32 %)
Market closed

Revenue has compounded at 20.9% per year over the past 10 years to 10.44 B SEK. Earnings per share have grown at 17.8% per year over the last 10 years. AddLife's net margin stands at 5.4%, down from 9.0% several years earlier. AddLife currently offers a dividend yield of about 0.47%. The payout ratio is around 16% of earnings. Analysts set a median price target of 218.28 SEK, implying 36.8% above the current price. Of 8 analysts, 5 rate the stock a buy — an overall Buy consensus. The stock trades about 19% above its 52-week low.

AddLife stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of AddLife over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how AddLife stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing AddLife's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

AddLife Stock Price History
DateAddLife Price
7/10/2026159.60 SEK
7/9/2026157.50 SEK
7/8/2026160.10 SEK
7/7/2026166.60 SEK
7/6/2026165.30 SEK
7/3/2026170.90 SEK
7/2/2026171.10 SEK
7/1/2026164.40 SEK
6/30/2026163.40 SEK
6/29/2026170.90 SEK
6/26/2026170.00 SEK
6/25/2026170.50 SEK
6/24/2026166.80 SEK
6/23/2026159.20 SEK
6/22/2026154.60 SEK
6/18/2026152.70 SEK
6/17/2026159.40 SEK
6/16/2026161.40 SEK
6/15/2026163.60 SEK
6/12/2026160.50 SEK
6/11/2026158.80 SEK
6/10/2026156.70 SEK
6/9/2026155.10 SEK
6/8/2026157.70 SEK
6/5/2026152.30 SEK
6/4/2026153.10 SEK
6/3/2026142.60 SEK
6/2/2026143.70 SEK
6/1/2026143.40 SEK
5/29/2026148.90 SEK
5/28/2026144.40 SEK
5/27/2026150.40 SEK
5/26/2026152.10 SEK
5/25/2026153.70 SEK
5/22/2026150.90 SEK
5/21/2026149.60 SEK
5/20/2026150.00 SEK
5/19/2026147.50 SEK
5/18/2026142.20 SEK
5/15/2026144.70 SEK
5/13/2026146.50 SEK
5/12/2026146.80 SEK
5/11/2026147.00 SEK
5/8/2026145.70 SEK
5/7/2026142.70 SEK
5/6/2026145.90 SEK
5/5/2026140.10 SEK
5/4/2026142.70 SEK
4/30/2026142.90 SEK
4/29/2026152.00 SEK
4/28/2026151.00 SEK
4/27/2026151.90 SEK
4/24/2026158.60 SEK
4/23/2026165.20 SEK
4/22/2026167.00 SEK
4/21/2026168.00 SEK
4/20/2026165.00 SEK
4/17/2026167.00 SEK
4/16/2026163.50 SEK
4/15/2026159.60 SEK
4/14/2026159.10 SEK
4/13/2026156.40 SEK
4/10/2026154.20 SEK
4/9/2026146.80 SEK
4/8/2026146.80 SEK
4/7/2026143.80 SEK
4/2/2026142.00 SEK
4/1/2026146.00 SEK
3/31/2026139.50 SEK
3/30/2026135.80 SEK
3/27/2026134.60 SEK
3/26/2026136.80 SEK
3/25/2026136.40 SEK
3/24/2026134.60 SEK
3/23/2026135.70 SEK
3/20/2026137.30 SEK
3/19/2026138.10 SEK
3/18/2026140.90 SEK
3/17/2026140.30 SEK
3/16/2026138.90 SEK
3/13/2026139.30 SEK
3/12/2026142.00 SEK
3/11/2026142.40 SEK
3/10/2026141.20 SEK
3/9/2026139.70 SEK
3/6/2026142.90 SEK
3/5/2026144.90 SEK
3/4/2026147.80 SEK
3/3/2026145.20 SEK
3/2/2026149.50 SEK
2/27/2026154.20 SEK
2/26/2026153.60 SEK
2/25/2026146.80 SEK
2/24/2026144.80 SEK
2/23/2026143.70 SEK
2/20/2026143.80 SEK
2/19/2026143.00 SEK
2/18/2026138.00 SEK
2/17/2026138.00 SEK
2/16/2026136.70 SEK
2/13/2026138.10 SEK
2/12/2026136.90 SEK
2/11/2026137.50 SEK
2/10/2026147.00 SEK
2/9/2026147.70 SEK
2/6/2026152.00 SEK
2/5/2026154.30 SEK
2/4/2026155.40 SEK
2/3/2026135.00 SEK
2/2/2026136.40 SEK
1/30/2026136.50 SEK
1/29/2026138.80 SEK
1/28/2026141.70 SEK
1/27/2026143.30 SEK
1/26/2026144.10 SEK
1/23/2026145.40 SEK
1/22/2026148.10 SEK
1/21/2026146.20 SEK
1/20/2026145.90 SEK
1/19/2026145.80 SEK
1/16/2026152.10 SEK
1/15/2026153.20 SEK
1/14/2026155.00 SEK
1/13/2026152.70 SEK
1/12/2026155.40 SEK
1/9/2026155.10 SEK
1/8/2026155.10 SEK
1/7/2026156.30 SEK
1/5/2026150.80 SEK
1/2/2026151.60 SEK
12/30/2025159.10 SEK
12/29/2025160.10 SEK
12/23/2025162.30 SEK
12/22/2025160.50 SEK
12/19/2025159.50 SEK
12/18/2025160.00 SEK
12/17/2025171.90 SEK
12/16/2025171.70 SEK
12/15/2025175.30 SEK
12/12/2025176.30 SEK
12/11/2025177.80 SEK
12/10/2025177.40 SEK
12/9/2025175.60 SEK
12/8/2025178.80 SEK
12/5/2025179.70 SEK
12/4/2025182.90 SEK
12/3/2025179.90 SEK
12/2/2025183.20 SEK
12/1/2025187.00 SEK
11/28/2025189.00 SEK
11/27/2025188.10 SEK
11/26/2025186.90 SEK
11/25/2025186.00 SEK
11/24/2025182.70 SEK
11/21/2025179.00 SEK
11/20/2025179.60 SEK
11/19/2025178.00 SEK
11/18/2025178.60 SEK
11/17/2025180.30 SEK
11/14/2025185.50 SEK
11/13/2025185.00 SEK
11/12/2025188.70 SEK
11/11/2025187.70 SEK
11/10/2025187.80 SEK
11/7/2025185.40 SEK
11/6/2025185.80 SEK
11/5/2025193.80 SEK
11/4/2025199.00 SEK
11/3/2025202.00 SEK
10/31/2025205.40 SEK
10/30/2025205.40 SEK
10/29/2025204.60 SEK
10/28/2025206.00 SEK
10/27/2025205.40 SEK
10/24/2025206.80 SEK
10/23/2025202.00 SEK
10/22/2025186.70 SEK
10/21/2025186.90 SEK
10/20/2025183.00 SEK
10/17/2025182.30 SEK
10/16/2025181.80 SEK
10/15/2025179.10 SEK
10/14/2025183.70 SEK
10/13/2025184.50 SEK
10/10/2025183.30 SEK
10/9/2025186.00 SEK
10/8/2025183.80 SEK
10/7/2025185.20 SEK
10/6/2025184.70 SEK
10/3/2025179.00 SEK
10/2/2025176.60 SEK
10/1/2025177.00 SEK
9/30/2025177.40 SEK
9/29/2025179.20 SEK
9/26/2025180.60 SEK
9/25/2025179.30 SEK
9/24/2025183.50 SEK
9/23/2025188.70 SEK
9/22/2025189.50 SEK
9/19/2025191.10 SEK
9/18/2025187.70 SEK
9/17/2025190.00 SEK
9/16/2025193.90 SEK
9/15/2025190.90 SEK
9/12/2025187.60 SEK
9/11/2025187.00 SEK
9/10/2025182.70 SEK
9/9/2025182.10 SEK
9/8/2025180.80 SEK
9/5/2025177.80 SEK
9/4/2025175.40 SEK
9/3/2025175.30 SEK
9/2/2025175.00 SEK
9/1/2025180.20 SEK
8/29/2025177.00 SEK
8/28/2025176.70 SEK
8/27/2025177.50 SEK
8/26/2025174.70 SEK
8/25/2025169.80 SEK
8/22/2025172.60 SEK
8/21/2025172.60 SEK
8/20/2025171.70 SEK
8/19/2025170.60 SEK
8/18/2025165.50 SEK
8/15/2025165.10 SEK
8/14/2025165.40 SEK
8/13/2025163.10 SEK
8/12/2025163.80 SEK
8/11/2025164.60 SEK
8/8/2025164.40 SEK
8/7/2025165.90 SEK
8/6/2025163.80 SEK
8/5/2025168.30 SEK
8/4/2025169.50 SEK
8/1/2025169.60 SEK
7/31/2025172.90 SEK
7/30/2025172.70 SEK
7/29/2025173.00 SEK
7/28/2025172.90 SEK
7/25/2025173.00 SEK
7/24/2025174.10 SEK
7/23/2025172.80 SEK
7/22/2025171.00 SEK
7/21/2025171.60 SEK
7/18/2025174.60 SEK
7/17/2025175.80 SEK
7/16/2025175.00 SEK
7/15/2025178.60 SEK
7/14/2025180.20 SEK
Access this data via the Eulerpool API
Get Free API Key

AddLife Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
7.99 B SEK
1.03 B SEK
718.60 M SEK
Jan 1, 2022
9.08 B SEK
838.00 M SEK
480.00 M SEK
Jan 1, 2023
9.69 B SEK
805.00 M SEK
190.00 M SEK
Jan 1, 2024
10.29 B SEK
801.00 M SEK
252.00 M SEK
Jan 1, 2025
10.44 B SEK
993.00 M SEK
560.00 M SEK
Jan 1, 2026 (e)
10.93 B SEK
1.01 B SEK
666.18 M SEK
Jan 1, 2027 (e)
11.58 B SEK
1.12 B SEK
709.88 M SEK
Jan 1, 2028 (e)
12.24 B SEK
1.12 B SEK
945.07 M SEK

AddLife Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 13, 2026, 1:27 AM
 
REVENUEB SEK
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB SEK
NET INCOMEM SEK
NET INCOME GROWTH%
DIV.SEK
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e
1.561.492.332.483.485.277.999.089.6910.2910.4410.9311.5812.24
–-4.9357.106.3440.2351.5751.5613.666.626.211.524.646.025.64
35.0234.4836.1836.0734.7235.0736.3638.0837.9638.2538.0938.0938.0938.09
0.550.510.840.901.211.852.913.463.683.933.984.164.414.66
77.0093.00120.00129.00140.00517.00718.00480.00190.00252.00560.00666.00709.00945.00
–20.7829.037.508.53269.2938.88-33.15-60.4232.63122.2218.936.4633.29
––1.502.202.200.501.502.001.200.500.751.501.501.50
–––46.67–-77.27200.0033.33-40.00-58.3350.00100.00––
86.82100.97102.21101.35111.08112.13119.97122.25121.86121.86121.86121.86121.86121.86
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales AddLife generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue AddLife retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare AddLife's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares AddLife has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against AddLife's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

AddLife stock margins

The AddLife margin analysis displays the gross margin, EBIT margin, as well as the profit margin of AddLife. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for AddLife.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
36.36 %
12.88 %
8.99 %
Jan 1, 2022
38.08 %
9.23 %
5.28 %
Jan 1, 2023
37.96 %
8.31 %
1.96 %
Jan 1, 2024
38.25 %
7.79 %
2.45 %
Jan 1, 2025
38.09 %
9.51 %
5.36 %
Jan 1, 2026 (e)
38.09 %
9.24 %
6.10 %
Jan 1, 2027 (e)
38.09 %
9.64 %
6.13 %
Jan 1, 2028 (e)
38.09 %
9.19 %
7.72 %

AddLife Stock Revenue, EBIT, Earnings per Share

The AddLife earnings per share therefore indicates how much revenue AddLife has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
66.62 SEK
8.58 SEK
5.99 SEK
Jan 1, 2022
74.30 SEK
6.85 SEK
3.93 SEK
Jan 1, 2023
79.48 SEK
6.61 SEK
1.56 SEK
Jan 1, 2024
84.41 SEK
6.57 SEK
2.07 SEK
Jan 1, 2025
85.69 SEK
8.15 SEK
4.60 SEK
Jan 1, 2026 (e)
89.66 SEK
8.29 SEK
5.47 SEK
Jan 1, 2027 (e)
95.06 SEK
9.17 SEK
5.83 SEK
Jan 1, 2028 (e)
100.42 SEK
9.22 SEK
7.76 SEK

AddLife business model & stock analysis

AddLife AB is a publicly listed company from Sweden that operates in the medical technology and healthcare industry. The company was founded in 2015 through the merger of several companies. AddLife AB is headquartered in Stockholm and currently employs over 2,000 employees in Sweden, Denmark, Finland, Norway, and Germany. The business model of AddLife AB is based on the acquisition and integration of leading technology companies in the healthcare industry. These companies are integrated into the AddLife Group and supported. Through collaboration within the group, synergies can be leveraged and competitiveness can be increased. AddLife offers its customers a wide range of products and services in various sectors. The company operates in the areas of diagnostics & life science, medical technology, and laboratory products. Diagnostics & life science includes products in the field of in vitro diagnostics, food analysis, nuclear medicine, and animal health. AddLife offers a wide range of products and services that are used in disease research and diagnostics. In the medical technology sector, AddLife AB offers products used by the medical technology industry, hospitals, and healthcare facilities. The product range includes surgical instruments, neurosurgery, orthopedics, and cardiology. AddLife is also involved in the project development of complete solutions for customers in this field. In the laboratory products sector, AddLife AB offers products and services for laboratories and research facilities. The product range includes laboratory equipment, laboratory consumables, and life science products. AddLife also offers services in the maintenance and validation of laboratory equipment. AddLife AB also has its own product brand, Labkotec, which manufactures products for fluid control and environmental and process condition monitoring. Labkotec operates internationally and offers products for various industries, such as the food and beverage industry, energy and environmental industry, steel industry, as well as the chemical and pharmaceutical industry. AddLife is known for its innovative products and solutions and works closely with customers to find individual solutions for their needs. The company sees itself as a provider of solutions and services for the medical industry and aims to improve the health and well-being of people through its products and services.

AddLife SWOT Analysis

Strengths

  • Established presence in the healthcare industry
  • Strong brand reputation
  • Diverse portfolio of healthcare products
  • Robust distribution network

Weaknesses

  • High dependency on a few key products
  • Limited international presence
  • Relatively small customer base

Opportunities

  • Growing demand for healthcare products
  • Expansion into new geographic markets
  • Increasing adoption of e-commerce in the healthcare sector

Threats

  • Intense competition from established players
  • Regulatory changes impacting the healthcare industry
  • Economic downturn affecting consumer spending on healthcare

AddLife Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

AddLife historical P/E ratio, EBIT multiple, and P/S ratio

AddLife annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

AddLife shares outstanding

The number of shares of AddLife was 121.86 M in 2025. This indicates how many shares AddLife is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
119.97 M Stocks
Jan 1, 2022
122.25 M Stocks
Jan 1, 2023
121.86 M Stocks
Jan 1, 2024
121.86 M Stocks
Jan 1, 2025
121.86 M Stocks
Jan 1, 2026 (e)
121.86 M Stocks
Jan 1, 2027 (e)
121.86 M Stocks
Jan 1, 2028 (e)
121.86 M Stocks

AddLife stock splits

In AddLife's history, there have been no stock splits.

AddLife Dividend History

10 years of dividend payments

YearAnnual DividendYoY ChangePayments
20261.50SEKYTD—1×
May 7, 20261.50SEK↑ 100.0%1/1
20250.75SEK↑ 50.0%1×
May 9, 20250.75SEK↑ 50.0%1/1
20240.50SEK↓ 58.3%1×
20231.20SEK↓ 40.0%1×
20222.00SEK↑ 33.3%1×
20211.50SEK↑ 200.0%1×
20200.50SEK↓ 77.3%1×
20192.20SEK 0.0%1×
20182.20SEK↑ 46.7%1×
20171.50SEK—1×

AddLife dividend history and estimates

In 2025, AddLife paid a dividend amounting to 0.75 SEK. Dividend means that AddLife distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.50 SEK
0.00 SEK
Jan 1, 2022
2.00 SEK
0.00 SEK
Jan 1, 2023
1.20 SEK
0.00 SEK
Jan 1, 2024
0.50 SEK
0.00 SEK
Jan 1, 2025
0.75 SEK
0.00 SEK
Jan 1, 2026
1.50 SEK
0.00 SEK
Jan 1, 2027 (e)
0.00 SEK
1.50 SEK
Jan 1, 2028 (e)
0.00 SEK
1.50 SEK

AddLife dividend payout ratio

In 2025, AddLife had a payout ratio of 16.32%. The payout ratio indicates the percentage of the company's profits that AddLife distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
25.04 %
Jan 1, 2022
50.94 %
Jan 1, 2023
76.96 %
Jan 1, 2024
24.18 %
Jan 1, 2025
16.32 %
Jan 1, 2026 (e)
27.44 %
Jan 1, 2027 (e)
25.75 %
Jan 1, 2028 (e)
19.34 %

Current AddLife forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.47 %
Buy62.50 % (5)
Hold37.50 % (3)
Sell0.00 % (0)
12M Price Target
218.28
Last Price
159.60
Currency
SEK
12M Return Potential
36.77 %
LTM Return
0 %

AddLife Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
7/13/20230.70SEK2.18 BSEK2023 Q2
4/26/20230.74SEK2.37 BSEK2023 Q1
2/2/20230.48SEK2.18 BSEK2022 Q4
10/27/20220.47SEK1.95 BSEK2022 Q3
7/15/20220.91SEK2.12 BSEK2022 Q2
4/28/20221.47SEK2.19 BSEK2022 Q1
2/4/20221.80SEK2.53 BSEK2021 Q4
2/13/20180.58SEK758.51 MSEK2017 Q4
10/26/20170.26SEK540.49 MSEK2017 Q3

EESG©

Eulerpool ESG Scorecard© for the AddLife stock

52/100
34
Environment
66
Social
55
Governance
E

Environment

20
Scope 1 - Direct Emissions5,088
Scope 2 - Indirect emissions from purchased energy1,374
Scope 3 - Indirect emissions within the value chain418,136
Total CO₂ emissions6,462
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees44
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

AddLife shareholder structure

% Name
10.29103%
SEB Investment Management AB
SEB Investment Management AB
9.06609%
AMF Tjänstepension AB
AMF Tjänstepension AB
6.48264%
ODIN Forvaltning AS
ODIN Forvaltning AS
5.81094%
Cliens Asset Management AB
Cliens Asset Management AB
5.00558%
Första AP-Fonden
Första AP-Fonden
4.89624%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
...

AddLife Executives and Management Board

FD

Mr. Fredrik Dalborg

(53)

President, Chief Executive Officer

Compensation10.30 M SEK
JS

Mr. Johan Sjoe

(58)

Independent Chairman of the Board

Compensation730,000.00 SEK
EN

Ms. Eva Nilsagard

(61)

Independent Director

Compensation430,000.00 SEK
EE

Ms. Eva Elmstedt

(65)

Independent Director

Compensation360,000.00 SEK
SH

Mr. Stefan Hedelius

(56)

Independent Director

Compensation360,000.00 SEK

Frequently asked questions about AddLife

The business model of AddLife AB revolves around the distribution and marketing of high-quality products and services within the life science sector. AddLife AB primarily focuses on three business areas: Labtech, Medtech, and Diagnostics. Labtech involves offering innovative solutions, including equipment and consumables, to laboratories and research institutions. Medtech includes the distribution of medical technology products for healthcare and rehabilitation. Diagnostics encompasses the supply of diagnostic products and services for medical laboratories. AddLife AB aims to provide its customers with comprehensive solutions, strong expertise, and reliable deliveries to meet their needs in the life science industry.

All fundamentals and in-depth analysis of AddLife

Our stock analysis for AddLife stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AddLife. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

AddLife Stock
AddLife Revenue→
AddLife Stock
AddLife Net Income→
AddLife Stock
AddLife P/E→
AddLife Stock
AddLife P/S→
AddLife Stock
AddLife EBIT→
AddLife Stock
AddLife Dividend→
AddLife Stock
AddLife Directors Dealings→
AddLife Stock
AddLife Stocks→
AddLife Stock
AddLife Market capitalization→
AddLife Stock
AddLife Debt→
AddLife Stock
AddLife Liabilities→
AddLife Stock
AddLife Equity→
AddLife Stock
AddLife AAQS→
AddLife Stock
AddLife Employees→
AddLife Stock
AddLife ROE→
AddLife Stock
AddLife ROA→
AddLife Stock
AddLife ROCE→
AddLife Stock
AddLife News→
AddLife Stock
AddLife Analyst Price Targets→

Health Stocks

Addus HomecareAddex TherapeuticsAdeshwar MeditexAddex TherapeuticsAdhera TherapeuticsADC TherapeuticsAdheris HealthADBiotech CoAdheriumAdaptive BiotechnologiesAdial PharmaceuticalsAdapthealthAll Stocks A–Z →